Pharmacokinetics of single dose intravenous infusion of magnesium isoglycyrrhizinate in patients with chronic hepatic impairment
- VernacularTitle:慢性肝病患者单剂量静脉滴注异甘草酸镁药代动力学研究
- Author:
xiao-dong, YAO
;
jin-fang, SHEN
;
yi-min, MAO
;
min-de, ZENG
- Publication Type:Journal Article
- Keywords:
magnesium isoglycyrrhizinate;
pharmacokinetics;
chronic hepatic impairment;
intravenous infusion
- From:Journal of Shanghai Jiaotong University(Medical Science)
2006;0(02):-
- CountryChina
- Language:Chinese
-
Abstract:
0.05). Conclusion The elimination half-life of magnesium isoglycyrrhizinate in patients with chronic hepatic impairment is 27 h,and the regiment of 100 mg once a day is recommended.
